The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.
R. Sauer
No relevant relationships to disclose
T. Liersch
No relevant relationships to disclose
S. Merkel
No relevant relationships to disclose
H. Becker
No relevant relationships to disclose
W. Hohenberger
No relevant relationships to disclose
H. Witzigmann
No relevant relationships to disclose
C. F. Hess
No relevant relationships to disclose
R. Fietkau
No relevant relationships to disclose
C. Wittekind
No relevant relationships to disclose
C. Roedel
Honoraria - Merck KGaA; Roche; Sanofi
Research Funding - Merck KGaA; Roche; Sanofi